Fennec Pharmaceuticals (FENC) Asset Writedowns and Impairment (2025)
Fennec Pharmaceuticals (FENC) posted Asset Writedowns and Impairment of $1.3 million for Q4 2025, up 174.18% on a QoQ basis from -$1.7 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Asset Writedowns and Impairment (2025) Analysis & Trends
Fennec Pharmaceuticals' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $773000.0 (changed N/A YoY) and the FY2025 annual result came in at $773000.0, up 49.52% from the prior year.
- Asset Writedowns and Impairment was $1.3 million for Q4 2025 at Fennec Pharmaceuticals, up from -$1.7 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.3 million in Q4 2025 and bottomed at -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Fennec Pharmaceuticals | 292.91 Mn | 256.13 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | -1.74 Mn |
| Sep 30, 2025 | -1.74 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |